Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Proteobionics: biomimetics in proteomics.

Andrei P Sommer1, Eleonora Gheorghiu

  • 1Central Institute of Biomedical Engineering, University of Ulm, 89081 Ulm, Germany. samoan@gmx.net

Journal of Proteome Research
|March 4, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expert consensus on vitamin D in osteoporosis.

Annals of joint·2025
Same author

Tutankhamun's Antimalarial Drug for Covid-19.

Drug research·2020
Same author

Quantum biology in low level light therapy: death of a dogma.

Annals of translational medicine·2020
Same author

Mitochondrial solar sensitivity: evolutionary and biomedical implications.

Annals of translational medicine·2020
Same author

Revisiting the Photon/Cell Interaction Mechanism in Low-Level Light Therapy.

Photobiomodulation, photomedicine, and laser surgery·2019
Same author

Mitochondrial cytochrome c oxidase is not the primary acceptor for near infrared light-it is mitochondrial bound water: the principles of low-level light therapy.

Annals of translational medicine·2019
Same journal

Proteomic Profiling of Endothelial Cells Under Laminar Shear Stress Confirms the Importance of KLF4 in the Regulation of Membrane Protein Expression Compared to Oscillatory Flow.

Journal of proteome research·2026
Same journal

Identification of Age-Associated Circulating Proteins and Lipids in 3800 Comorbidity-Enriched Older Adults from Japan-Based Cohorts Using Olink Assays and MRM Mass Spectrometry.

Journal of proteome research·2026
Same journal

Molecular Solution to the Paradox of Ancient Brain Preservation.

Journal of proteome research·2026
Same journal

From Method-Defined Signals to Reference Measurement Procedures: Two Decades of Mass Spectrometry-Based ProGRP Quantification.

Journal of proteome research·2026
Same journal

Proteomic Profiling of Extracellular Vesicle-Enriched Plasma Using Mag-Net for Biomarker Discovery in Pancreatic Ductal Adenocarcinoma.

Journal of proteome research·2026
Same journal

Computationally Efficient Bayesian Estimation of Graphical Networks for Omics Data.

Journal of proteome research·2026
See all related articles

Proteobionics, a new field, uses nature's protein functions to create advanced biomedical products. This approach, inspired by nanobacteria, models drug delivery systems using protein functions and mineral shells.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Proteomics

Background:

  • Proteomics, the study of protein complements of genomes, emerged a decade ago.
  • Bionics applies nature-optimized structures to technology.
  • Previous work analyzed nanobacteria survival and applied it to drug delivery models.

Purpose of the Study:

  • Introduce and exemplify proteobionics, a novel branch of nanoproteomics.
  • Demonstrate the potential of utilizing naturally occurring protein functions for biomedical applications.
  • Highlight the conversion of survival-related protein functions and mineral shells into advanced therapeutic designs.

Main Methods:

  • Analysis of microbial genomes and their proteomes.
  • Investigation of survival mechanisms in nanobacteria.

Related Experiment Videos

  • Modeling of protein functions and nanoscale mineral shells for drug delivery applications.
  • Main Results:

    • Established proteobionics as a new field merging proteomics and bionics.
    • Presented examples of proteobionics in nanoproteomics.
    • Demonstrated the successful translation of natural survival strategies into biomedical models.

    Conclusions:

    • Proteobionics offers a promising avenue for designing innovative biomedical products and therapies.
    • The study highlights the potential of nature-inspired designs in advanced drug delivery.
    • Further exploration of proteobionics is warranted for future therapeutic advancements.